There were 14 press releases posted in the last 24 hours and 158,450 in the last 365 days.

Intercept to Present at Upcoming Investor Conferences in May

/EIN News/ -- NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that management will be presenting at the following upcoming investor conferences:

  • Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV at 11:20 a.m. PT on Tuesday, May 14, 2019
  • UBS Global Healthcare Conference in New York, NY at 1:00 p.m. ET on Tuesday, May 21, 2019
  • RBC Capital Markets Global Healthcare Conference in New York, NY at 11:30 a.m. ET on Wednesday, May 22, 2019

Webcast information for these events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Justine O’Malley
+1-646-931-1180
investors@interceptpharma.com

Media inquiries: media@interceptpharma.com
 

Intercept Pharmaceuticals, Inc. logo


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.